Continuous hyperthermic peritoneal perfusion: Difference between revisions
CSV import |
No edit summary |
||
| Line 34: | Line 34: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 16:51, 22 March 2025
Continuous Hyperthermic Peritoneal Perfusion (CHPP) is a type of hyperthermia therapy used to treat peritoneal carcinomatosis, a condition where cancer has spread to the lining of the abdomen.
Procedure[edit]
In CHPP, the abdomen is heated to a high temperature and filled with a chemotherapy solution. This is done to kill cancer cells that may be in the abdomen. The solution is circulated continuously for 1 to 2 hours and then drained.
Uses[edit]
CHPP is used to treat peritoneal carcinomatosis from colorectal cancer, appendix cancer, stomach cancer, ovarian cancer, mesothelioma, and primary peritoneal carcinoma.
Benefits[edit]
The benefits of CHPP include the ability to deliver high doses of chemotherapy directly to the cancer cells in the abdomen, while minimizing the amount of drug that reaches the rest of the body. This can reduce side effects and increase the effectiveness of the treatment.
Risks[edit]
The risks of CHPP include infection, bleeding, damage to the intestines or other organs, and side effects from the chemotherapy drugs.
Alternatives[edit]
Alternatives to CHPP include systemic chemotherapy, radiation therapy, and surgery. The choice of treatment depends on the type and stage of the cancer, the patient's overall health, and the patient's preferences.


